Clinical Pharmacology Details


Idarubicin Hydrochloride


View Drug Forms

Indications & Dose:


Acute non-lympbocytic leukaemia,


30 mg/m2 daily for 3 days alone or 15-30 mg/m2 daily for 3 days in combination therapy


Advanced breast cancer,


45 mg/m2 alone, as a single dose or divided over 3 consecutive days; repeat every 3-4 weeks
Max. cumulative dose by mouth (for all indications) 400 mg/m2

Contraindications:

Side Effects:

Cautions:

Hepatic and renal impairment and caution in handling-irritant to tissues

Precautions:

Interaction:

Warnings:

Adverse Effects:

Lactations:

Special Precautions:

Counselling:

Side Effects Or Adverse Reactions:

Patient And Carer Advice: